Helicobacter pylori (H. Pylori)

Helicobacter pylori (H. pylori) is a spiral-shaped bacterium that infects the stomach lining, affecting roughly half the world’s population. The H. pylori antibody blood test detects IgG antibodies your immune system produces in response to this infection. While the bacteria itself lives in the stomach, the antibodies circulate in blood, making a simple blood draw sufficient for detection.

Why does this matter? H. pylori is the primary cause of peptic ulcers and a major risk factor for stomach cancer. Most infected people have no symptoms, but the bacteria can silently damage the stomach lining over years or decades. Identifying and treating H. pylori infection can heal ulcers, prevent recurrence, and may reduce stomach cancer risk. The blood test offers a convenient, non-invasive way to screen for exposure to this important pathogen.

However, the antibody test has an important limitation: antibodies persist for months to years after successful treatment, so a positive result doesn’t distinguish between active infection and past (cured) infection. For confirming cure after treatment, other tests are preferred. Understanding when the blood test is appropriate — and when it isn’t — helps ensure proper diagnosis and management.

Order Your H. pylori Test

---

Key Benefits of Testing

The H. pylori antibody blood test provides a convenient, non-invasive screening method for detecting exposure to this common stomach infection. It requires only a simple blood draw with no special preparation, making it accessible and easy to perform. The test is particularly useful for initial screening in patients with dyspepsia (indigestion) or suspected ulcer disease who have never been tested or treated for H. pylori.

Blood testing also works well for epidemiological studies and screening in populations where other tests aren’t readily available. It’s less affected by medications that can interfere with other H. pylori tests, though results still require careful interpretation.

---

What Does This Test Measure?

The H. pylori antibody test measures IgG antibodies against Helicobacter pylori in your blood. When your immune system encounters H. pylori bacteria in the stomach, it produces antibodies to fight the infection. These antibodies enter the bloodstream where they can be detected by laboratory testing.

About H. pylori

Helicobacter pylori is a remarkably adapted bacterium that has evolved to survive in the harsh acidic environment of the stomach. It burrows into the mucus layer protecting the stomach lining and produces urease, an enzyme that neutralizes stomach acid in its immediate vicinity. This creates a more hospitable microenvironment where the bacteria can thrive.

H. pylori infection is typically acquired in childhood and persists for life unless treated with antibiotics. Transmission occurs person-to-person, likely through oral-oral or fecal-oral routes, and is more common in crowded living conditions and areas with poor sanitation. Once established, the infection causes chronic inflammation of the stomach lining (gastritis), which in some people progresses to ulcers or, rarely, stomach cancer.

How Antibody Testing Works

When your immune system detects H. pylori, it produces several types of antibodies. IgM antibodies appear first during acute infection but decline quickly. IgG antibodies develop later and persist long-term — these are what the blood test measures. IgA antibodies are also produced but are less commonly tested.

The presence of IgG antibodies indicates your immune system has encountered H. pylori at some point. However — and this is the crucial limitation — IgG antibodies remain detectable for months to years after the bacteria have been eliminated, whether through treatment or (rarely) spontaneous clearance. A positive antibody test therefore means “exposed at some point” rather than “currently infected.”

Blood Test vs. Other H. pylori Tests

Several tests can detect H. pylori, each with advantages and limitations:

• Blood antibody test: Convenient but can’t distinguish active from past infection; not useful for confirming cure
• Urea breath test: Detects active infection only; excellent for diagnosis and confirming cure after treatment
• Stool antigen test: Detects active infection; good for diagnosis and confirming cure
• Endoscopy with biopsy: Direct visualization and tissue sampling; can test for bacteria and assess damage

The blood test is best for initial screening in untreated patients. For confirming cure after treatment, the breath test or stool antigen test are preferred because they only detect active infection.

---

Why This Test Matters

H. pylori Causes Most Ulcers

Before H. pylori was discovered in 1982, peptic ulcers were blamed on stress and spicy food. We now know that H. pylori causes the majority of stomach ulcers and duodenal ulcers. The bacteria damages the protective mucus layer, allowing acid to erode the underlying tissue. Eradicating H. pylori heals ulcers and dramatically reduces recurrence — from about 70% to less than 10%.

H. pylori Increases Stomach Cancer Risk

H. pylori infection is classified as a Group 1 carcinogen by the World Health Organization. Chronic infection causes ongoing inflammation and cellular changes that can, over decades, progress to stomach cancer. While most infected people never develop cancer, H. pylori is present in the majority of gastric cancer cases. Treating the infection may reduce this risk, particularly if done before precancerous changes develop.

Many Infections Are Silent

Most people with H. pylori have no symptoms at all. The bacteria can live in the stomach for years or decades causing chronic low-grade inflammation without obvious problems. Screening allows detection of these silent infections, particularly in people with risk factors or family history of stomach problems.

Treatment Is Effective

H. pylori can be eradicated with a combination of antibiotics and acid-suppressing medication, typically taken for 10-14 days. Success rates exceed 80-90% with appropriate regimens. Identifying infection through testing enables this effective treatment.

Value of Testing in Appropriate Situations

For patients with dyspepsia who have never been tested, a positive antibody test supports the diagnosis and justifies treatment. In areas where H. pylori is common and other tests aren’t available, blood testing provides valuable screening information. The key is understanding what a positive result means and when other tests are more appropriate.

---

What Can Affect Test Results?

Causes of Positive Results

Current active H. pylori infection is one cause — the immune system is actively fighting bacteria present in the stomach. This is the result you’re looking for when screening untreated patients.

Past H. pylori infection (now cleared) is the major interpretive challenge. Antibodies persist for many months to years after successful treatment. A previously treated patient may test positive on antibody testing even though no bacteria remain. This is why the blood test shouldn’t be used to confirm cure.

Cross-reactivity with antibodies to other bacteria is theoretically possible but uncommon with modern specific assays.

Causes of Negative Results

No H. pylori exposure — the person has never been infected. This is the straightforward interpretation of a negative result.

Early infection before antibody development (rare) — it takes 3-4 weeks after infection for detectable antibodies to appear. Very recent infections might be missed.

Immunocompromised patients may not mount adequate antibody responses, potentially causing false negatives. Other testing methods may be more reliable in these patients.

Very low-level infection might occasionally produce antibody levels below the test’s detection threshold.

Medications That Don’t Significantly Affect Blood Testing

Unlike the breath test and stool antigen test, the antibody blood test is less affected by recent antibiotic use or proton pump inhibitor (PPI) therapy. These medications can suppress H. pylori and cause false-negative results on tests that detect active infection, but antibodies already in blood remain detectable. This is an advantage of blood testing in certain situations.

---

When Should You Get Tested?

Dyspepsia (indigestion symptoms) in patients who have never been tested or treated for H. pylori is a primary indication. Symptoms include upper abdominal discomfort, bloating, early fullness, nausea, and burning sensations. A “test and treat” strategy — testing for H. pylori and treating if positive — is recommended for these patients.

Suspected or known peptic ulcer disease warrants H. pylori testing. Since the bacteria causes most ulcers, confirming and treating infection is essential for healing and preventing recurrence.

Family history of stomach cancer may prompt screening, as H. pylori infection combined with genetic factors increases risk. Some guidelines recommend testing and treating first-degree relatives of gastric cancer patients.

Long-term NSAID or aspirin use combined with H. pylori infection increases ulcer risk significantly. Testing and treating before starting long-term NSAID therapy may be appropriate.

Unexplained iron deficiency anemia has been linked to H. pylori infection in some cases. The bacteria may interfere with iron absorption or cause occult blood loss.

When other tests aren’t available, blood testing provides a practical alternative for detecting H. pylori exposure.

When Blood Testing Is NOT Recommended

• Confirming cure after treatment: Antibodies persist long after bacteria are gone; use breath or stool test instead
• Previously treated patients: A positive result doesn’t indicate treatment failure
• When active infection status is critical: Other tests directly detect bacteria

Order Your Test

---

Understanding Your Results

H. pylori antibody results are typically reported as positive, negative, or equivocal/borderline. Some labs also report quantitative antibody levels.

Positive Result

A positive result means H. pylori antibodies were detected, indicating exposure to the bacteria at some point. In a patient who has never been tested or treated for H. pylori and has relevant symptoms, a positive result strongly supports current infection and justifies treatment.

However, remember the key limitation: a positive result in someone previously treated for H. pylori may simply reflect persistent antibodies from past infection, not treatment failure. If confirming cure is important, use a breath or stool test instead.

Negative Result

A negative result means no H. pylori antibodies were detected. In most cases, this indicates the person has never been infected. False negatives are uncommon but can occur in early infection (before antibodies develop), immunocompromised patients, or rarely with very low bacterial loads.

A negative result in an untreated patient with ongoing dyspepsia suggests H. pylori is not the cause, and other diagnoses should be considered.

Equivocal/Borderline Result

Some results fall in an indeterminate range. This may warrant repeat testing in 2-4 weeks or using a different testing method (breath or stool test) to clarify the diagnosis.

Quantitative Results

Some labs report antibody levels numerically. While higher levels generally correlate with infection, there’s overlap between infected and uninfected individuals. Quantitative results don’t reliably distinguish active from past infection or predict severity.

---

What to Do About Abnormal Results

For Positive Results in Untreated Patients

Treatment is typically indicated for patients with positive H. pylori serology plus symptoms (dyspepsia, ulcer disease) or risk factors (family history of gastric cancer, planned long-term NSAID use).

Standard treatment involves triple or quadruple therapy for 10-14 days:

• Proton pump inhibitor (PPI) to reduce acid
• Two or more antibiotics (commonly clarithromycin, amoxicillin, metronidazole, or others depending on local resistance patterns)
• Sometimes bismuth is added for quadruple therapy

Confirm eradication after treatment using breath test or stool antigen test (not the blood test) — wait at least 4 weeks after completing therapy. Confirmation is especially important for ulcer disease and when symptoms persist.

For Positive Results in Previously Treated Patients

Don’t assume treatment failure based on positive serology alone. Antibodies persist long after successful treatment. If confirmation of cure is needed, use breath or stool testing.

For Negative Results

H. pylori is unlikely to be causing symptoms in untreated patients with negative serology. Consider other causes of dyspepsia including GERD, functional dyspepsia, medication effects, or other GI conditions. Further evaluation (possibly endoscopy) may be appropriate depending on symptoms and risk factors.

---

Related Health Conditions

Peptic Ulcer Disease

H. pylori is the leading cause of both gastric (stomach) and duodenal ulcers. The bacteria disrupts the protective mucus barrier, allowing acid to damage the underlying tissue. Eradicating H. pylori heals ulcers and prevents recurrence far better than acid suppression alone. Learn more →

Gastric Cancer

Chronic H. pylori infection significantly increases stomach cancer risk. The bacteria causes progressive gastric inflammation and cellular changes over decades. While most infected people never develop cancer, H. pylori is found in the majority of gastric adenocarcinomas. Learn more →

Chronic Gastritis

H. pylori causes chronic inflammation of the stomach lining (gastritis) in virtually all infected individuals. This chronic gastritis is usually asymptomatic but represents ongoing tissue damage. Over time, it can progress to atrophic gastritis and intestinal metaplasia — precancerous changes. Learn more →

MALT Lymphoma

Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach is strongly associated with H. pylori infection. Remarkably, early-stage gastric MALT lymphoma often regresses completely with H. pylori eradication alone, without chemotherapy. Learn more →

Functional Dyspepsia

Some patients with functional dyspepsia (chronic indigestion without structural cause) have H. pylori infection. Treating the infection provides symptom relief in a subset of these patients, though response rates are modest compared to ulcer healing. Learn more →

Iron Deficiency Anemia

H. pylori infection is a recognized cause of unexplained iron deficiency anemia, even without visible bleeding. The bacteria-induced chronic gastritis reduces stomach acid, impairing iron absorption. H. pylori may also compete for iron and cause microscopic blood loss. Guidelines recommend testing for H. pylori in patients with unexplained iron deficiency anemia, particularly when it doesn’t respond to iron supplementation. Eradicating the infection often improves iron status. Learn more →

---

Why Testing Matters

H. pylori infection affects billions of people worldwide and causes significant disease including ulcers and stomach cancer. The blood antibody test provides an accessible, non-invasive screening method for detecting exposure to this important pathogen. While the test has limitations — particularly its inability to distinguish active from past infection — it remains valuable for initial screening in appropriate patients. Understanding when blood testing is useful and when other tests are preferred ensures accurate diagnosis and effective management.

---

Related Biomarkers Often Tested Together

H. pylori Stool Antigen — Detects active infection; useful for diagnosis and confirming cure.

Complete Blood Count (CBC) — May show anemia if chronic blood loss or iron deficiency present.

Iron Studies — H. pylori can cause iron deficiency; evaluate if anemia present.

Vitamin B12 — Chronic gastritis from H. pylori can impair B12 absorption.

Gastrin — May be elevated with H. pylori infection or atrophic gastritis.

Note: Information provided in this article is for educational purposes and doesn’t replace personalized medical advice.